Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Human Gene Therapy|November 14, 1997
Retrovirus-mediated gene transfer of the multidrug resistance-associated protein (MRP) cDNA protects cells from chemotherapeutic agentsV D'Hondt, M Caruso, A Bank
Stem Cells (Dayton, Ohio)|May 1, 1993
IL-3 and peripheral blood stem cell harvestingT Guillaume, V D'Hondt, M Symann
Current Gene Therapy|July 12, 2002
Chemoprotection and selection by chemotherapy of multidrug resistance-associated protein-1 (MRP1) transduced cellsV D'Hondt, M Symann, J P Machiels
European Journal of Cancer (Oxford, England : 1990)|June 9, 2005
Will the dark sky over advanced renal cell carcinoma soon become brighter?V D'Hondt, T Gil, Y Lalami, et al.
Revue Medicale De Bruxelles|December 12, 2002
[Acute interstitial pneumonia and bronchial cancer]Th Berghmans, D De Becker, V D'Hondt, et al.
Bone Marrow Transplantation|October 12, 1999
Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factorsJ C Goeminne, T Guillaume, M Salmon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Current management of ovarian carcinosarcomaM S Mano, D D Rosa, E Azambuja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib studyV D'Hondt, P Weynants, Y Humblet, et al.
Bone Marrow Transplantation|March 1, 1994
Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot studyV D'Hondt, T Guillaume, Y Humblet, et al.
Blood|May 1, 1995
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib studyV D'Hondt, Y Humblet, T Guillaume, et al.
Pageof 2